A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Baxter International Inc stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 1,563,567 shares of BAX stock, worth $51 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,563,567
Previous 488,847 219.85%
Holding current value
$51 Million
Previous $16.4 Million 263.08%
% of portfolio
0.11%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$32.85 - $40.26 $35.3 Million - $43.3 Million
1,074,720 Added 219.85%
1,563,567 $59.4 Million
Q2 2024

Aug 14, 2024

BUY
$32.87 - $43.55 $3.63 Million - $4.81 Million
110,494 Added 29.2%
488,847 $16.4 Million
Q1 2024

May 15, 2024

BUY
$37.88 - $43.77 $14.3 Million - $16.6 Million
378,353 New
378,353 $16.2 Million
Q3 2023

Nov 14, 2023

SELL
$37.32 - $49.29 $34.2 Million - $45.2 Million
-917,227 Reduced 91.36%
86,720 $3.27 Million
Q2 2023

Aug 14, 2023

SELL
$39.98 - $47.68 $12 Million - $14.4 Million
-301,400 Reduced 23.09%
1,003,947 $45.7 Million
Q1 2023

May 15, 2023

BUY
$37.58 - $52.57 $29.8 Million - $41.7 Million
792,600 Added 154.58%
1,305,347 $52.9 Million
Q4 2022

Feb 14, 2023

SELL
$49.7 - $57.71 $14,910 - $17,313
-300 Reduced 0.06%
512,747 $26.1 Million
Q3 2022

Nov 14, 2022

BUY
$53.86 - $66.8 $4.77 Million - $5.92 Million
88,600 Added 20.87%
513,047 $27.6 Million
Q2 2022

Aug 15, 2022

SELL
$63.83 - $80.0 $9.47 Million - $11.9 Million
-148,400 Reduced 25.91%
424,447 $27.3 Million
Q1 2022

May 16, 2022

SELL
$76.85 - $89.45 $39.2 Million - $45.7 Million
-510,700 Reduced 47.13%
572,847 $44.4 Million
Q4 2021

Feb 14, 2022

SELL
$74.57 - $87.19 $3.91 Million - $4.58 Million
-52,500 Reduced 4.62%
1,083,547 $93 Million
Q3 2021

Nov 15, 2021

BUY
$73.77 - $83.61 $43.3 Million - $49.1 Million
587,600 Added 107.14%
1,136,047 $91.4 Million
Q2 2021

Aug 16, 2021

SELL
$80.5 - $88.01 $30.1 Million - $33 Million
-374,455 Reduced 40.57%
548,447 $44.2 Million
Q1 2021

May 17, 2021

BUY
$76.38 - $86.03 $27 Million - $30.4 Million
353,900 Added 62.2%
922,902 $77.8 Million
Q4 2020

Feb 16, 2021

BUY
$75.39 - $82.36 $358,102 - $391,210
4,750 Added 0.84%
569,002 $45.7 Million
Q3 2020

Nov 16, 2020

SELL
$78.33 - $90.73 $36.4 Million - $42.2 Million
-465,100 Reduced 45.18%
564,252 $45.4 Million
Q2 2020

Aug 14, 2020

SELL
$78.66 - $94.14 $13.6 Million - $16.3 Million
-172,676 Reduced 14.37%
1,029,352 $88.6 Million
Q1 2020

May 15, 2020

BUY
$71.57 - $93.3 $22 Million - $28.6 Million
306,712 Added 34.26%
1,202,028 $97.6 Million
Q4 2019

Feb 14, 2020

BUY
$76.7 - $88.45 $7.66 Million - $8.84 Million
99,919 Added 12.56%
895,316 $74.9 Million
Q3 2019

Nov 14, 2019

BUY
$81.4 - $89.78 $17.5 Million - $19.4 Million
215,600 Added 37.19%
795,397 $69.6 Million
Q2 2019

Aug 14, 2019

SELL
$73.44 - $82.41 $1.34 Million - $1.51 Million
-18,266 Reduced 3.05%
579,797 $47.5 Million
Q1 2019

May 15, 2019

BUY
$64.48 - $81.31 $9.54 Million - $12 Million
147,926 Added 32.86%
598,063 $48.6 Million
Q4 2018

Feb 14, 2019

SELL
$61.45 - $77.8 $14.5 Million - $18.4 Million
-236,028 Reduced 34.4%
450,137 $29.6 Million
Q3 2018

Nov 14, 2018

SELL
$70.71 - $77.75 $13.3 Million - $14.7 Million
-188,734 Reduced 21.57%
686,165 $52.9 Million
Q2 2018

Aug 14, 2018

BUY
$63.43 - $75.41 $19.1 Million - $22.7 Million
301,500 Added 52.58%
874,899 $64.6 Million
Q1 2018

May 15, 2018

SELL
$62.56 - $72.26 $27.5 Million - $31.7 Million
-439,142 Reduced 43.37%
573,399 $37.3 Million
Q4 2017

Feb 14, 2018

BUY
$61.45 - $66.05 $18.3 Million - $19.7 Million
298,015 Added 41.71%
1,012,541 $65.5 Million
Q3 2017

Nov 14, 2017

BUY
$59.5 - $64.61 $42.5 Million - $46.2 Million
714,526
714,526 $44.8 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.4B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.